Pharmaceutical

Sanofi and Orano Med link for radioligand therapy development

Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.

Oct 20, 2024 - 04:00
Sanofi and Orano Med link for radioligand therapy development
Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.
Read the original article

Tags:

Previous Article

Unresolved clawback issues obstruct Greece’s potential pharmaceutical framework ...

Next Article

Opioid addiction market to reach $2.4 billion across 8MM by 2033

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

MSD’s Keytruda wins expanded FDA combo approval in cervical cancer

MSD’s Keytruda wins expanded FDA combo approval in cerv...

Jan 15, 2024

Vinod Khosla’s bold AI prediction, digital therapeutics trial updates, & funding for AI in pharma

Vinod Khosla’s bold AI prediction, digital therapeutics...

May 5, 2023

Diabesity: Overlapping pathophysiology informs multi-indication treatment

Diabesity: Overlapping pathophysiology informs multi-in...

Aug 15, 2024